Brinzolamide is a topical carbonic anhydrase inhibitor that reduces aqueous humour production, used for the management of glaucoma and ocular hypertension. Simson Pharma's Brinzolamide reference standard and impurities support the precise impurity control required of this ophthalmic suspension.
Simson Pharma Global Ltd. (UK) and Simson Pharma Global LLC (USA) supply high-quality Brinzolamide Reference Standards, pharmacopoeial reference materials, and its related impurities to pharmaceutical manufacturers, CROs, analytical laboratories, universities, and regulatory organizations worldwide. To service the Europe and America market efficiently, Simson Pharma Limited has set up Simson Pharma Global Ltd. in United Kingdom and Simson Pharma Global LLC in USA respectively.